Beetroot (Nitrates)

Beetroot (Beta vulgaris) is a root vegetable that has been cultivated in the Mediterranean and European regions since antiquity, with documented use dating back to ancient Egypt and classical Greece. The modern interest in beetroot as a cardiovascular and athletic supplement derives primarily from its exceptionally high content of inorganic nitrate (NO3-), concentrated in the vacuoles of the root parenchyma at levels of 1,500 to 4,000 mg per kg fresh weight, several-fold higher than other nitrate-containing vegetables such as spinach, arugula, and lettuce. A standard 70 mL concentrated beetroot shot delivers 300 to 600 mg of inorganic nitrate, a dose range that consistently produces hemodynamic and exercise performance effects in clinical trials. Beetroot also contains betalain pigments (betanin, isobetanin, vulgaxanthin), betaine (trimethylglycine), polyphenols, and folate, but the clinical evidence attributes the primary cardiovascular and performance effects specifically to the nitrate content rather than these secondary components, based on head-to-head comparisons with nitrate-depleted beetroot juice controls.

The central mechanism by which beetroot exerts cardiovascular and performance effects is the nitrate-nitrite-nitric oxide (NO3- to NO2- to NO) pathway, a physiological cascade that produces nitric oxide completely independently of the NOS3-encoded endothelial nitric oxide synthase (eNOS) enzyme. Dietary nitrate is absorbed in the small intestine, enters systemic circulation, and is actively concentrated in salivary glands to 10 to 20 times the plasma concentration. When this concentrated saliva is swallowed, the salivary nitrate is reduced to nitrite by oral commensal bacteria, particularly Veillonella parvula, Haemophilus parainfluenzens, and Actinomyces odontolyticus, which express nitrate reductase enzymes lacking in mammalian cells. This salivary nitrite is then converted to nitric oxide in the acidic stomach environment through disproportionation at low pH, or in hypoxic/ischemic tissues by xanthine oxidoreductase (XOR) and other tissue reductases. The NO produced by this pathway activates soluble guanylate cyclase (sGC) and raises cGMP in vascular smooth muscle, producing relaxation and vasodilation by the same final common pathway as eNOS-derived NO.

The relevance of dietary nitrate to NOS3 (eNOS) biology is the complementarity between the enzymatic (eNOS-dependent) and non-enzymatic (nitrate-dependent) routes to NO production. The eNOS enzyme is the primary endogenous source of vascular NO, using L-arginine and molecular oxygen as substrates and requiring the cofactors BH4, FAD, FMN, heme, and calmodulin for coupled function. When eNOS function is impaired, such as by the rs1799983 (Glu298Asp) genetic variant that reduces eNOS protein stability, by BH4 depletion from oxidative stress causing eNOS uncoupling, by aging-related reduction in eNOS expression, or by post-translational modifications from reactive oxygen species, the enzymatic NO route is compromised. The dietary nitrate pathway bypasses all of these vulnerabilities: it requires no enzyme activity, no cofactors, and no oxygen, becoming even more active under hypoxic conditions where XOR-mediated nitrite reduction accelerates. For the approximately 25 to 35 percent of Europeans carrying the NOS3 Glu298Asp variant, dietary nitrate supplementation represents a uniquely appropriate intervention that compensates directly for the impaired genetic pathway.

The clinical evidence base for dietary nitrate spans three primary domains: cardiovascular (blood pressure reduction, endothelial function improvement), athletic performance (exercise economy, time-trial performance), and cognitive function (cerebral blood flow, reaction time). The Siervo et al. 2013 meta-analysis (n=254) and Ashor et al. 2017 meta-analysis (n=629) establish the blood pressure evidence; the Cermak et al. 2012 meta-analysis establishes the athletic performance evidence; and an emerging body of RCTs establishes the cognitive evidence. Beetroot juice (concentrated shots) is the most clinically practical form, as nitrate content is standardized and verified by manufacturers, unlike fresh beets whose nitrate content varies substantially with soil nitrate levels, variety, season, and storage conditions. The performance and blood pressure effects have been replicated across multiple independent research groups using both commercial beetroot shots and pharmaceutical-grade sodium nitrate, establishing that nitrate is the active component rather than the non-nitrate beetroot components.

Mechanism of Action

Nitrate-Nitrite-Nitric Oxide Pathway

The nitrate-nitrite-NO (NO3- to NO2- to NO) cascade is the central mechanism by which dietary beetroot produces cardiovascular and performance effects. After ingestion, inorganic nitrate (NO3-) is absorbed in the small intestine and enters systemic circulation with greater than 90 percent efficiency. The key transformation begins in the salivary glands, which actively concentrate nitrate from plasma at 10 to 20 times the plasma concentration through an active transport mechanism. This salivary nitrate is then reduced to nitrite (NO2-) by nitrate reductase enzymes expressed in oral commensal bacteria, primarily Veillonella parvula, Haemophilus parainfluenzens, and Actinomyces odontolyticus. Mammalian cells do not express nitrate reductase, so this bacterial step is obligatory for the conversion.

When nitrite-containing saliva is swallowed, it encounters the acidic environment of the stomach (pH 1 to 2 under fasting conditions), where nitrous acid (HNO2) forms and rapidly disproportionates to generate NO and other reactive nitrogen intermediates. Additionally, plasma nitrite is reduced to NO in tissues under hypoxic or ischemic conditions by xanthine oxidoreductase (XOR), deoxyhemoglobin, and cytochrome c oxidase. The NO produced through all of these routes activates soluble guanylate cyclase (sGC) in vascular smooth muscle, generating cyclic GMP (cGMP), which activates protein kinase G (PKG) and produces smooth muscle relaxation, vasodilation, and reduced peripheral vascular resistance. This is the same final common pathway as eNOS-derived NO, explaining why dietary nitrate produces the same end-organ effects as endogenous NO production.

eNOS Backup Pathway and NOS3 Variant Compensation

The eNOS enzyme encoded by NOS3 is the primary endogenous vascular source of NO, using L-arginine, NADPH, and molecular oxygen as substrates, and requiring the cofactors tetrahydrobiopterin (BH4), FAD, FMN, heme, and calmodulin. When eNOS function is intact, it generates NO primarily in response to shear stress and receptor-mediated calcium signals. The dietary nitrate pathway is mechanistically distinct: it requires no enzyme activity, no cofactors, no calcium signaling, and no oxygen, and it actually becomes more active under hypoxic conditions where XOR-mediated nitrite reduction accelerates.

The NOS3 rs1799983 variant (Glu298Asp) substitutes aspartate for glutamate at position 298 of the eNOS protein, destabilizing the protein and increasing its susceptibility to proteolytic cleavage, reducing the amount of functional eNOS in endothelial cells. This variant is present in approximately 25 to 35 percent of Europeans and is associated with reduced endothelium-dependent vasodilation, higher blood pressure, and increased cardiovascular risk. Since the dietary nitrate pathway completely bypasses eNOS, it provides NO production capacity that is entirely unaffected by this genetic variant or by acquired eNOS dysfunction from oxidative stress-induced BH4 depletion (which uncouples eNOS to produce superoxide rather than NO). This mechanistic specificity makes beetroot nitrate supplementation uniquely appropriate for the NOS3 Glu298Asp subpopulation.

Mitochondrial Efficiency Enhancement

A mechanistically distinct and particularly important property of dietary nitrate is its enhancement of mitochondrial ATP synthesis efficiency in skeletal muscle. Larsen et al. demonstrated that sodium nitrate supplementation reduced the oxygen cost of submaximal cycling by 5 to 7 percent without reducing ATP production, indicating an increase in the P/O ratio (ATP generated per oxygen atom consumed). The proposed mechanism involves NO-mediated inhibition of cytochrome c oxidase (Complex IV) through competitive binding to the oxygen-binding heme site, reducing the rate of electron transport without fully blocking it. This reduction in Complex IV activity decreases the proton leak across the inner mitochondrial membrane and improves the coupling efficiency of oxidative phosphorylation.

The effect is most pronounced in Type II (fast-twitch glycolytic) muscle fibers, which normally have lower mitochondrial density and less efficient oxidative phosphorylation than Type I (slow-twitch oxidative) fibers. By improving the efficiency of Type II fiber mitochondria specifically, dietary nitrate supplements the aerobic capacity of muscle fibers that are disproportionately recruited at higher exercise intensities. The practical result is a reduced oxygen cost at submaximal intensities (improving time to exhaustion at fixed workloads) and a reduced oxygen cost at maximal intensity (improving peak power output and time-trial performance).

Epigenetic Modulation and Vascular Gene Expression

Emerging evidence suggests that chronic dietary nitrate supplementation modulates vascular gene expression through NO-dependent epigenetic mechanisms. NO produced from dietary nitrate can S-nitrosylate key transcription factors and epigenetic enzymes, including histone deacetylases (HDACs). HDAC inhibition by NO leads to increased histone acetylation at eNOS promoter regions, increasing eNOS expression in endothelial cells. This creates a potential positive feedback loop: dietary nitrate increases eNOS expression, which increases eNOS-derived NO production, further reinforcing the vascular NO signaling capacity. Additionally, NO modulates the activity of the Nrf2 transcription factor through S-nitrosylation of Keap1, increasing antioxidant enzyme expression and reducing oxidative stress that would otherwise uncouple eNOS.

Clinical Evidence

Blood Pressure Meta-analyses

The antihypertensive effect of dietary nitrate is among the best-documented effects of any dietary supplement. The Siervo et al. 2013 meta-analysis (PMID 24858657, 16 RCTs, n=254) reported mean systolic BP reductions of 4.4 mmHg and diastolic reductions of 1.1 mmHg. Ashor et al. 2017 (PMID 28675494, 22 trials, n=629) confirmed these effects and identified stronger responses in populations with baseline hypertension, where systolic reductions approached 8 to 10 mmHg. These magnitudes are clinically significant: a 4 to 5 mmHg reduction in systolic BP is estimated to reduce stroke risk by approximately 14 percent and coronary artery disease risk by approximately 9 percent in epidemiological models.

The blood pressure effects are rapid (peaking 2 to 3 hours after ingestion) and persist with daily supplementation. Crucially, studies using nitrate-depleted beetroot juice as controls (by passing juice through a nitrate-removing filter) have consistently shown that the BP effect is attributable specifically to nitrate rather than to the betalain pigments, betaine, or polyphenols also present in beetroot, validating the nitrate-centric mechanism.

Exercise Performance

Cermak et al. 2012 meta-analysis (PMID 21454802, 7 RCTs) established consistent improvements in time to exhaustion (12.5 to 17 percent) and time-trial performance (1 to 3 percent). The performance benefits are observable in recreational to moderately trained athletes but are attenuated in highly trained elite athletes, presumably because high training-induced eNOS activity already provides near-maximal NO production. For exercise performance, the evidence supports consuming concentrated beetroot shots or 500 mL of beetroot juice 2 to 3 hours before the event, with 6 to 10 days of daily pre-loading potentially providing additional benefit compared to single-dose protocols.

Endothelial Function

Ashor et al. 2017 meta-analysis also found significant improvements in flow-mediated dilation (FMD) of the brachial artery, a validated surrogate marker of endothelial health and cardiovascular risk. The improvements were largest in populations with baseline endothelial dysfunction, suggesting that dietary nitrate is most beneficial when the endogenous NO system is most compromised, consistent with the backup pathway concept. FMD improvements of 1 to 2 percentage points are associated with meaningful reductions in cardiovascular event risk in prospective data.

Cognitive and Cerebrovascular Effects

Kelly et al. 2013 (PMID 23001745) used arterial spin labeling MRI to demonstrate that beetroot juice consumption increased cerebral blood flow to frontal white matter regions in older adults. These hypoperfused regions are vulnerable to age-related vascular insufficiency and are critical for executive function, working memory, and attention. Acute improvements in reaction time and cognitive processing speed following dietary nitrate have been reported in multiple subsequent studies, with the cerebrovascular blood flow increase being the most plausible mechanism. Whether chronic dietary nitrate supplementation reduces dementia risk requires prospective trials with cognitive endpoints.

Beetroot Nitrate Versus L-Arginine

A practically important comparison is between dietary nitrate and L-arginine as routes to enhance NO bioavailability. L-arginine is the substrate for eNOS and increases NO production by providing more substrate for the enzymatic reaction. However, L-arginine supplementation requires fully functional eNOS: it does not compensate for eNOS genetic variants, eNOS uncoupling from BH4 depletion, or aging-related eNOS downregulation. Dietary nitrate, by contrast, completely bypasses eNOS and provides NO regardless of eNOS status. For individuals with NOS3 variants or acquired eNOS dysfunction, dietary nitrate is mechanistically superior to L-arginine as a means of restoring NO signaling. The two approaches may be complementary in individuals with intact eNOS: L-arginine ensures adequate substrate supply while dietary nitrate provides eNOS-independent NO through a parallel route.

Dosing Guidance

The evidence-supported dose for blood pressure effects is 300 to 400 mg of dietary nitrate daily, equivalent to approximately 70 to 140 mL of concentrated beetroot shots or 250 to 500 mL of standard beetroot juice. For acute exercise performance, 400 to 500 mg of nitrate consumed 2 to 3 hours before the event is the most studied protocol. Concentrated standardized beetroot shots are the most reliable format due to consistent nitrate content per serving. Antibacterial mouthwash use before consumption should be avoided as it abolishes the microbial nitrate-to-nitrite conversion step that is required for bioactivity. For individuals on antihypertensive medications, blood pressure monitoring is appropriate when starting daily beetroot supplementation due to additive hypotensive effects.